BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 20355204)

  • 1. Generic sample preparation and dual polarity liquid chromatography-time-of-flight mass spectrometry for high-throughput screening in doping analysis.
    Kolmonen M; Leinonen A; Kuuranne T; Pelander A; Ojanperä I
    Drug Test Anal; 2009 Jun; 1(6):250-66. PubMed ID: 20355204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A general screening method for doping agents in human urine by solid phase extraction and liquid chromatography/time-of-flight mass spectrometry.
    Kolmonen M; Leinonen A; Pelander A; Ojanperä I
    Anal Chim Acta; 2007 Feb; 585(1):94-102. PubMed ID: 17386652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventive doping control screening analysis of prohibited substances in human urine using rapid-resolution liquid chromatography/high-resolution time-of-flight mass spectrometry.
    Vonaparti A; Lyris E; Angelis YS; Panderi I; Koupparis M; Tsantili-Kakoulidou A; Peters RJ; Nielen MW; Georgakopoulos C
    Rapid Commun Mass Spectrom; 2010 Jun; 24(11):1595-609. PubMed ID: 20486255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput screening for various classes of doping agents using a new 'dilute-and-shoot' liquid chromatography-tandem mass spectrometry multi-target approach.
    Guddat S; Solymos E; Orlovius A; Thomas A; Sigmund G; Geyer H; Thevis M; Schänzer W
    Drug Test Anal; 2011; 3(11-12):836-50. PubMed ID: 22135086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generic sample preparation combined with high-resolution liquid chromatography-time-of-flight mass spectrometry for unification of urine screening in doping-control laboratories.
    Peters RJ; Oosterink JE; Stolker AA; Georgakopoulos C; Nielen MW
    Anal Bioanal Chem; 2010 Apr; 396(7):2583-98. PubMed ID: 20155493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of two major urinary metabolites of the PPARdelta-agonist GW1516 and implementation of the drug in routine doping controls.
    Thevis M; Möller I; Thomas A; Beuck S; Rodchenkov G; Bornatsch W; Geyer H; Schänzer W
    Anal Bioanal Chem; 2010 Apr; 396(7):2479-91. PubMed ID: 19946680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput and sensitive screening by ultra-performance liquid chromatography tandem mass spectrometry of diuretics and other doping agents.
    Ventura R; Roig M; Montfort N; Sáez P; Bergés R; Segura J
    Eur J Mass Spectrom (Chichester); 2008; 14(3):191-200. PubMed ID: 18708699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-detection of corticosteroids in sports doping and veterinary control using high-resolution liquid chromatography/time-of-flight mass spectrometry.
    Touber ME; van Engelen MC; Georgakopoulus C; van Rhijn JA; Nielen MW
    Anal Chim Acta; 2007 Mar; 586(1-2):137-46. PubMed ID: 17386705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass spectrometric characterization of a prolyl hydroxylase inhibitor GSK1278863, its bishydroxylated metabolite, and its implementation into routine doping controls.
    Thevis M; Milosovich S; Licea-Perez H; Knecht D; Cavalier T; Schänzer W
    Drug Test Anal; 2016 Aug; 8(8):858-63. PubMed ID: 26361079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass spectrometric determination of gonadotrophin-releasing hormone (GnRH) in human urine for doping control purposes by means of LC-ESI-MS/MS.
    Thomas A; Geyer H; Kamber M; Schänzer W; Thevis M
    J Mass Spectrom; 2008 Jul; 43(7):908-15. PubMed ID: 18563864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction of solid-phase microextraction as a high-throughput sample preparation tool in laboratory analysis of prohibited substances.
    Boyacı E; Gorynski K; Rodriguez-Lafuente A; Bojko B; Pawliszyn J
    Anal Chim Acta; 2014 Jan; 809():69-81. PubMed ID: 24418135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of ultra-high pressure liquid chromatography coupled to high resolution mass spectrometry for fast screening in high throughput doping control.
    Musenga A; Cowan DA
    J Chromatogr A; 2013 May; 1288():82-95. PubMed ID: 23540767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fully automated determination of nicotine and its major metabolites in whole blood by means of a DBS online-SPE LC-HR-MS/MS approach for sports drug testing.
    Tretzel L; Thomas A; Piper T; Hedeland M; Geyer H; Schänzer W; Thevis M
    J Pharm Biomed Anal; 2016 May; 123():132-40. PubMed ID: 26896632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doping control analysis of methoxyphenamine using liquid chromatography-tandem mass spectrometry.
    Thevis M; Sigmund G; Koch A; Guddat S; Maurer HH; Schänzer W
    Eur J Mass Spectrom (Chichester); 2008; 14(3):145-52. PubMed ID: 18708694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a direct high-capacity target screening approach for urine drug testing using liquid chromatography-time-of-flight mass spectrometry.
    Saleh A; Stephanson NN; Granelli I; Villén T; Beck O
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Nov; 909():6-13. PubMed ID: 23153637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of new exemestane metabolites by liquid chromatography interfaced to electrospray-tandem mass spectrometry.
    de Albuquerque Cavalcanti G; Carius Garrido B; Dias Leal F; Costa Padilha M; Mazzarino M; de la Torre X; Botre F; Radler de Aquino Neto F
    J Steroid Biochem Mol Biol; 2011 Nov; 127(3-5):248-54. PubMed ID: 21924357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Wrong-way-round ionization' and screening for doping substances in human urine by high-performance liquid chromatography/orbitrap mass spectrometry.
    Virus ED; Sobolevsky TG; Rodchenkov GM
    J Mass Spectrom; 2012 Mar; 47(3):381-91. PubMed ID: 22431466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of over 100 drugs in horse urine using automated on-line solid-phase extraction coupled to liquid chromatography-high resolution mass spectrometry for doping control.
    Kwok WH; Choi TLS; Tsoi YYK; Leung GNW; Wan TSM
    J Chromatogr A; 2017 Mar; 1490():89-101. PubMed ID: 28215405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive screening of anabolic steroids, corticosteroids, and acidic drugs in horse urine by solid-phase extraction and liquid chromatography-mass spectrometry.
    Ho EN; Leung DK; Wan TS; Yu NH
    J Chromatogr A; 2006 Jul; 1120(1-2):38-53. PubMed ID: 16631183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.